SMC approves new cancer drugs, among others by Anna Smith | May 14, 2019 | News | 0 Drugs for breast cancer, skin cancer and schizophrenia have been approved. Read More
EU nod for Gedeon’s novel antipsychotic Reagila by Selina McKee | Jul 19, 2017 | News | 0 European regulators have approved Gedeon Richter’s novel antipsychotic Reagila as a new option for the treatment of patients with schizophrenia. Read More
Eleven therapies put forward for EU approval by Selina McKee | May 22, 2017 | News | 0 Eleven new medicines have been put forward for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including new options for a rare eye disease, schizophrenia and cartilage defects. Read More